Xonotlite Nanowire-Containing Bioactive Scaffolds for the Therapy of Defective Adipose Tissue in Breast Cancer.
Hongshi MaHui ZhuangDong ZhaiJinfu WuJingge MaZhiguang HuanChengtie WuPublished in: Nano letters (2023)
Considering the challenge in the treatment of severe breast tumor patients, xonotlite nanowire-containing bioactive scaffolds (Fe 3 O 4 -CS-GelMA) were fabricated by the 3D-printing technique for the therapy of injured adipose tissue after surgery. Importantly, benefiting from the excellent magnetothermal performance of Fe 3 O 4 microspheres, Fe 3 O 4 -CS-GelMA scaffolds could effectively kill tumor cells in vitro and suppress breast cancer in vivo under an alternating magnetic field, and the tumor did not recur in 2 weeks. In addition, attributed to the released bioactive inorganic ions, Fe 3 O 4 -CS-GelMA composite scaffolds could effectively promote the expression of adipogenesis-related genes and proteins of adipose-derived stem cells (ADSCs) via the PI3K-AKT signaling pathway in vitro . Furthermore, Fe 3 O 4 -CS-GelMA scaffolds with ADSCs could obviously stimulate the formation of adipose in vivo , compared with that of pure GelMA without inorganic components. Therefore, this study offers a promising strategy for the therapy of breast tumors after the surgical excision of breast carcinoma.
Keyphrases
- tissue engineering
- adipose tissue
- signaling pathway
- insulin resistance
- end stage renal disease
- ejection fraction
- high fat diet
- room temperature
- poor prognosis
- peritoneal dialysis
- newly diagnosed
- prognostic factors
- epithelial mesenchymal transition
- type diabetes
- pi k akt
- skeletal muscle
- early onset
- mass spectrometry
- mesenchymal stem cells
- quantum dots
- bone marrow
- high resolution
- induced apoptosis
- combination therapy
- wound healing
- endoplasmic reticulum stress
- gestational age
- perovskite solar cells
- cell therapy
- aqueous solution